BlueJeans Network Eliminates the ‘Video Tax’ with Introduction of BlueJeans Huddle
Dec 08, 2016 14:30 pm UTC| Business
MOUNTAIN VIEW, Calif., Dec. 08, 2016 -- BlueJeans Network, the global leader in cloud-based video communication services, today unveiled BlueJeans Huddle, a cloud-connected video system that introduces a whole new way...
Dec 08, 2016 14:30 pm UTC| Business
BURBANK, Calif., Dec. 08, 2016 -- Imaging3, Inc. (OTCQB:IGNG) announced today that the United States Supreme Court denied John M. Vuksich’s petition for a rehearing of an order denying a petition for a writ of...
Vapogenix Secures $8.2 Million in Series C Funding to Advance Innovative Therapy for Wound Pain
Dec 08, 2016 14:30 pm UTC| Business
HOUSTON, Dec. 08, 2016 -- Vapogenix, Inc., a clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million to advance the development of its lead product, a locally-acting...
Petrone Worldwide, Inc. (OTCQB: PFWI) Uplists to the OTCQB® Venture Market
Dec 08, 2016 14:30 pm UTC| Business
Weston, Florida , Dec. 08, 2016 -- Petrone Worldwide, Inc. (OTCQB: PFWI), a leader in the hospitality industry with global operations capabilities announces today that it has successfully been verified by OTC Markets...
Griffin Announces Fiscal 2016 Fourth Quarter Leasing
Dec 08, 2016 14:23 pm UTC| Business
NEW YORK, Dec. 08, 2016 -- Griffin Industrial Realty, Inc. (NASDAQ:GRIF) (“Griffin”) announced that in its fiscal 2016 fourth quarter, it had a net increase of approximately 173,000 square feet in space leased and...
Dec 08, 2016 14:15 pm UTC| Business
Miami, Florida, Dec. 08, 2016 -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), reports the TherOZap™ technology being developed by its licensing partner, The Jenex Corporation NEX:JEN.H, will undergo testing of...
MacroGenics to Host 2016 R&D Day
Dec 08, 2016 14:15 pm UTC| Business
ROCKVILLE, MD, Dec. 08, 2016 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment...